Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics
Jens Björkman, Andreas Hecker
Manufacturing Quality Control for Plasmid DNA Critical Starting Materials
A Frazer, L R. Salvitti, S Lovatt et al
Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance
Olaf Stamm, Horst Ruppach, Minu Youngkin
Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study
M Dingle, A Carwell, M J. Miller et al
Fit-for-purpose analytical development for an emerging cell therapy landscape
Jie Wei, Damian Marshall, Florian Durst
Strategies for streamlined manufacturing and analytics in CGT development
Laura Mueller, Silvio Weber, Dirk Windgassen
Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success
Peter Szaraz, Tessel Hammink
AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques
Andreja Livk, Sebastijan Peljhan
Modernizing viral clearance study strategy: regulatory updates and industry best practices
Audrey Chang, Kathleen Kenney
Big pharma case study: alpha testing of a generic anti-AAV kit and comparison to in-house methods
Kira Hedström, Eva-Maria Thüring
From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development
Audrey Chang, Joe Newcome
Advances in the separation and analysis of AAV-based gene delivery vectors
Jukka Kervinen, Yuliya McAnany
Process in the product: a new analytical tool for AAV production optimization and monitoring
Blaž Bakalar, Ivana Petrović Koshmak
Emerging global trends and regulatory opportunities in cell therapies for cancer
Kim Watanabe, Sushama Sankpal, Kasey Kime
Harnessing flow cytometry for high-throughput screening in immunotherapy development
Kevin Chen, Jonah Riddell, Raffaello Cimbro
Application of CGE in cell and gene therapy
Ryan Hylands, Luiza Chrojan